Trial intelligence / Profile preview

MDMA, oxytocin, and 5-HT1A blockade in prosocial behavior

NL-OMON36227Not yet recruiting

Sponsor
Dr. Kim Kuypers, Dept. of NP & PP, Fac of FPN, UM P.O.Box 616 6200 MD Maastricht tel: +31433881902 fax: +31433884560 email: [email protected]
Start
Feb 2011
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Countries
1
01

Overview

Trial of midomafetamine, oxytocin and pindolol (4 arms), sponsored by Dr. Kim Kuypers, Dept. of NP & PP, Fac of FPN, UM P.O.Box 616 6200 MD Maastricht tel: +31433881902 fax: +31433884560 email: [email protected]. Primary endpoints: Empathy and social interaction task outcomes and Treatment and oxytocin blood concentrations. Planned start Feb 2011; status: not yet recruiting.

02

Drugs

midomafetamineoxytocinpindolol

Beyond the preview

Go deeper on NL-OMON36227.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36227.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call